RT Journal Article
SR Electronic
T1 Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004025
DO 10.1136/jitc-2021-004025
VO 10
IS 2
A1 Seto, Takashi
A1 Nosaki, Kaname
A1 Shimokawa, Mototsugu
A1 Toyozawa, Ryo
A1 Sugawara, Shunichi
A1 Hayashi, Hidetoshi
A1 Murakami, Haruyasu
A1 Kato, Terufumi
A1 Niho, Seiji
A1 Saka, Hideo
A1 Oki, Masahide
A1 Yoshioka, Hiroshige
A1 Okamoto, Isamu
A1 Daga, Haruko
A1 Azuma, Koichi
A1 Tanaka, Hiroshi
A1 Nishino, Kazumi
A1 Tohnai, Rie
A1 Yamamoto, Nobuyuki
A1 Nakagawa, Kazuhiko
YR 2022
UL http://jitc.bmj.com/content/10/2/e004025.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.